brodalumab-话题@MedSci - 梅斯（MedSci）

#brodalumab#

12篇内容 | 1166人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1539055, encodeId=7b16153905554, content=<a href='/topic/show?id=33a73e441c' target=_blank style='color:#2F92EE;'>#brodalumab#</a>, objectTitle=J Eur Acad Dermatol Venereol：Brodalumab治疗中重度斑块状银屑病的长期疗效和安全性 , objectType=article, longId=736658, objectId=f14be366588f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f14be366588f, replyNumber=0, likeNumber=79, createdTime=2022-08-24, rootId=0, userName=zxl733, userId=e88e13104080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f14be366588f, moduleTitle=J Eur Acad Dermatol Venereol：Brodalumab治疗中重度斑块状银屑病的长期疗效和安全性 , moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f14be366588f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539054, encodeId=bf4a153905495, content=<a href='/topic/show?id=33a73e441c' target=_blank style='color:#2F92EE;'>#brodalumab#</a>, objectTitle=Arthritis Rheumatol：Brodalumab可有效治疗头皮和指甲银屑病的病损, objectType=article, longId=301790, objectId=90ed301e90ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90ed301e90ac, replyNumber=0, likeNumber=84, createdTime=2022-03-29, rootId=0, userName=zxl733, userId=e88e13104080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90ed301e90ac, moduleTitle=Arthritis Rheumatol：Brodalumab可有效治疗头皮和指甲银屑病的病损, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=90ed301e90ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539053, encodeId=f6bc153905375, content=<a href='/topic/show?id=33a73e441c' target=_blank style='color:#2F92EE;'>#brodalumab#</a>, objectTitle=JEADV：布达鲁（brodalumab）单抗治疗中重度斑块型银屑病的远期疗效和安全性, objectType=article, longId=301181, objectId=285330118105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=285330118105, replyNumber=0, likeNumber=71, createdTime=2022-03-21, rootId=0, userName=zxl733, userId=e88e13104080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=285330118105, moduleTitle=JEADV：布达鲁（brodalumab）单抗治疗中重度斑块型银屑病的远期疗效和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=285330118105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539052, encodeId=dd6b1539052c4, content=<a href='/topic/show?id=33a73e441c' target=_blank style='color:#2F92EE;'>#brodalumab#</a>, objectTitle=ARD:柏达鲁单抗（Brodalumab）治疗银屑病关节炎效果分析, objectType=article, longId=216820, objectId=6862216820bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6862216820bd, replyNumber=0, likeNumber=80, createdTime=2021-09-09, rootId=0, userName=zxl733, userId=e88e13104080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6862216820bd, moduleTitle=ARD:柏达鲁单抗（Brodalumab）治疗银屑病关节炎效果分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6862216820bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539051, encodeId=3e15153905189, content=<a href='/topic/show?id=33a73e441c' target=_blank style='color:#2F92EE;'>#brodalumab#</a>, objectTitle=Kyowa Hakko Kirin公布其白细胞介素-17受体A单抗brodalumab治疗轴性脊柱关节炎患者的临床3期阳性结果, objectType=article, longId=168718, objectId=1557168e1835, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1557168e1835, replyNumber=0, likeNumber=96, createdTime=2019-06-20, rootId=0, userName=zxl733, userId=e88e13104080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1557168e1835, moduleTitle=Kyowa Hakko Kirin公布其白细胞介素-17受体A单抗brodalumab治疗轴性脊柱关节炎患者的临床3期阳性结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1557168e1835)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539050, encodeId=40f5153905011, content=<a href='/topic/show?id=33a73e441c' target=_blank style='color:#2F92EE;'>#brodalumab#</a>, objectTitle=FDA批准IL17A抗体brodalumab, objectType=article, longId=89400, objectId=759d894008d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=759d894008d, replyNumber=0, likeNumber=69, createdTime=2017-02-22, rootId=0, userName=zxl733, userId=e88e13104080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=759d894008d, moduleTitle=FDA批准IL17A抗体brodalumab, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=759d894008d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539049, encodeId=05d5153904939, content=<a href='/topic/show?id=33a73e441c' target=_blank style='color:#2F92EE;'>#brodalumab#</a>, objectTitle=Am J Gastroenterol：brodalumab会导致活动性克罗恩病恶化, objectType=article, longId=74847, objectId=c865e48473c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c865e48473c, replyNumber=0, likeNumber=57, createdTime=2016-08-11, rootId=0, userName=zxl733, userId=e88e13104080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c865e48473c, moduleTitle=Am J Gastroenterol：brodalumab会导致活动性克罗恩病恶化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c865e48473c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539048, encodeId=77d515390481b, content=<a href='/topic/show?id=33a73e441c' target=_blank style='color:#2F92EE;'>#brodalumab#</a>, objectTitle=鸡肋陷阱：IL17受体A抗体brodalumab价廉物不美, objectType=article, longId=73094, objectId=a033e30945f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a033e30945f, replyNumber=0, likeNumber=71, createdTime=2016-07-20, rootId=0, userName=zxl733, userId=e88e13104080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a033e30945f, moduleTitle=鸡肋陷阱：IL17受体A抗体brodalumab价廉物不美, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a033e30945f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539047, encodeId=5e9b153904ec2, content=<a href='/topic/show?id=33a73e441c' target=_blank style='color:#2F92EE;'>#brodalumab#</a>, objectTitle=NEJM：Brodalumab治疗中度至重度银屑病，效果良好, objectType=article, longId=56831, objectId=f9e65683121, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9e65683121, replyNumber=0, likeNumber=66, createdTime=2015-10-03, rootId=0, userName=zxl733, userId=e88e13104080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9e65683121, moduleTitle=NEJM：Brodalumab治疗中度至重度银屑病，效果良好, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f9e65683121)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539046, encodeId=ae581539046cd, content=<a href='/topic/show?id=33a73e441c' target=_blank style='color:#2F92EE;'>#brodalumab#</a>, objectTitle=斑块性银屑病新药brodalumab临床III期结果优异, objectType=article, longId=43289, objectId=6752432895c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6752432895c, replyNumber=0, likeNumber=62, createdTime=2014-11-30, rootId=0, userName=zxl733, userId=e88e13104080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6752432895c, moduleTitle=斑块性银屑病新药brodalumab临床III期结果优异, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6752432895c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539045, encodeId=6f061539045ba, content=<a href='/topic/show?id=33a73e441c' target=_blank style='color:#2F92EE;'>#brodalumab#</a>, objectTitle=牛皮癣新药IL-17受体单抗brodalumab三期研究获得成功, objectType=article, longId=34817, objectId=57b53481e9f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57b53481e9f, replyNumber=0, likeNumber=130, createdTime=2014-05-17, rootId=0, userName=zxl733, userId=e88e13104080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57b53481e9f, moduleTitle=牛皮癣新药IL-17受体单抗brodalumab三期研究获得成功, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=57b53481e9f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539044, encodeId=df851539044d7, content=<a href='/topic/show?id=33a73e441c' target=_blank style='color:#2F92EE;'>#brodalumab#</a>, objectTitle=Am J Respir Crit Care Med：Brodalumab对中-重度哮喘无治疗作用, objectType=article, longId=27934, objectId=ca992e934cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca992e934cd, replyNumber=0, likeNumber=69, createdTime=2013-12-13, rootId=0, userName=zxl733, userId=e88e13104080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca992e934cd, moduleTitle=Am J Respir Crit Care Med：Brodalumab对中-重度哮喘无治疗作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ca992e934cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

brodalumab

2020-05-29

zxl733 (审核中...)

前往app查看评论内容

#brodalumab#

J Eur Acad Dermatol Venereol：Brodalumab治疗中重度斑块状银屑病的长期疗效和安全性

2022-08-24

zxl733 (审核中...)

前往app查看评论内容

#brodalumab#

Arthritis Rheumatol：Brodalumab可有效治疗头皮和指甲银屑病的病损

2022-03-29

zxl733 (审核中...)

前往app查看评论内容

#brodalumab#

JEADV：布达鲁（brodalumab）单抗治疗中重度斑块型银屑病的远期疗效和安全性

2022-03-21

zxl733 (审核中...)

前往app查看评论内容

#brodalumab#

ARD:柏达鲁单抗（Brodalumab）治疗银屑病关节炎效果分析

2021-09-09

zxl733 (审核中...)

前往app查看评论内容

#brodalumab#

Kyowa Hakko Kirin公布其白细胞介素-17受体A单抗brodalumab治疗轴性脊柱关节炎患者的临床3期阳性结果

2019-06-20

zxl733 (审核中...)

前往app查看评论内容

#brodalumab#

FDA批准IL17A抗体brodalumab

2017-02-22

zxl733 (审核中...)

前往app查看评论内容

#brodalumab#

Am J Gastroenterol：brodalumab会导致活动性克罗恩病恶化

2016-08-11

zxl733 (审核中...)

前往app查看评论内容

#brodalumab#

鸡肋陷阱：IL17受体A抗体brodalumab价廉物不美

2016-07-20

zxl733 (审核中...)

前往app查看评论内容

#brodalumab#

NEJM：Brodalumab治疗中度至重度银屑病，效果良好

2015-10-03

zxl733 (审核中...)

前往app查看评论内容

#brodalumab#

斑块性银屑病新药brodalumab临床III期结果优异

2014-11-30

zxl733 (审核中...)

前往app查看评论内容

#brodalumab#

牛皮癣新药IL-17受体单抗brodalumab三期研究获得成功

2014-05-17

zxl733 (审核中...)

前往app查看评论内容

#brodalumab#

Am J Respir Crit Care Med：Brodalumab对中-重度哮喘无治疗作用

2013-12-13

科室
- - 订阅+
  - 更多科室
工具
服务